Silence Therapeutics (SLN) Earnings Date & Reports
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SLN is expected to report earnings to rise 11.14% to -7 cents per share on March 13
Q4'23
Est.
$-0.08
Q3'23
Beat
by $0.10
Q2'23
Beat
by $0.05
Q1'23
Beat
by $0.03
Q4'22
Beat
by $0.46
The last earnings report on November 14 showed earnings per share of -7 cents, beating the estimate of -17 cents. With 279.78K shares outstanding, the current market capitalization sits at 134.59M.